Last reviewed · How we verify
NCT05046093
Clinical Outcomes of Cryobiopsy for Peripheral Pulmonary Lesions - A Prospective Pilot Study
NA trial testing Transbronchial cryobiopsy in Lung Nodule in 50 participants. Completed in 30 July 2023.
30 July 2022
Quick facts
| Lead sponsor | Pusan National University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 50 |
| Start date | 1 December 2021 |
| Primary completion | 30 July 2022 |
| Estimated completion | 30 July 2023 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Transbronchial cryobiopsy
Conditions studied
- Lung Nodule — all drugs for Lung Nodule →
Sponsor
Pusan National University Hospital
Who can join
18 and older, any sex, with Lung Nodule. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
As the former radial endobronchial ultrasound (R-EBUS) guided transbronchial forcep biopsy of peripheral pulmonary nodules has some limitations, the purpose of this study is to investigate a novel biopsy technique, transbronchial cryobiopsy, in patients with peripheral pulmonary nodules.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical outcomes of transbronchial cryobiopsy using a 1.1-mm diameter cryoprobe for peripheral lung lesions - A prospective pilot study.
Kim SH, Mok J, Kim S, Yoo WH, et al · · 2023 · cited 18× · PMID 37380091 · DOI 10.1016/j.rmed.2023.107338
Verify or expand the search:
- PubMed search for NCT05046093
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transbronchial cryobiopsy
Trials testing the same drug.
- NCT07130110 — BAL Contribution to Lung Cryo-TBB in ILD · NA · completed
- NCT03704233 — The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Diseases · unknown
Other recruiting trials for Lung Nodule
Currently open trials in the same condition.
- NCT06597968 — Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool · recruiting
- NCT07098884 — Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos · recruiting
- NCT06838806 — Epigenetic Nucleosomes in Plasma for Pulmonary Nodule Differentiation · recruiting
- NCT06054854 — Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease) · recruiting
Other Pusan National University Hospital trials
Trials by the same sponsor.
- NCT07073365 — Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor The · Phase 2 · recruiting
- NCT06878495 — Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease · NA · not yet recruiting
- NCT06805123 — Early Feeding Versus Delayed Feeding After Colorectal Endoscopic Submucosal Dissection · NA · recruiting
- NCT06752395 — Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions · NA · enrolling by invitation
- NCT07455552 — Comparison of Telemedicine-based and Home-based Inspiratory Muscle Training After Lung Resection in High-risk Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05046093 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pusan National University Hospital
- Last refreshed: 3 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05046093.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing